HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

NEXT STORY
Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress
PREV STORY
Apollomics, Inc. Receives China Investigational New Drug Approval for APL-102 to Initiate a Phase 1 Study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aravive to Participate in Upcoming Virtual Investor Conferences in September

author_avatar
NASDAQ Market News

NGM Bio Initiates Expansion of Ongoing Phase 1b Proof-of-Concept Study of NGM120 in Patients with Metastatic Pancreatic Cancer

author_avatar
NASDAQ Market News

iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News